BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7744590)

  • 21. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definitive irradiation in the treatment of Hodgkin's disease. Analysis of outcome, prognostic factors, and long-term complications.
    Sears JD; Greven KM; Ferree CR; D'Agostino RB
    Cancer; 1997 Jan; 79(1):145-51. PubMed ID: 8988739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
    J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.
    Czyz J; Szydlo R; Knopinska-Posluszny W; Hellmann A; Gozdzik J; Hansz J; Smolewski P; Robak T; Osowiecki M; Walewski J; Avigdor A; Nagler A; Zemelka T; Pawlicki M; Sawicki Z; Wojtukiewicz M; Kachel L; Holowiecki J; Charlinski G; Jedrzejczak WW
    Bone Marrow Transplant; 2004 Jun; 33(12):1225-9. PubMed ID: 15094747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
    Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
    Mendoza E; Territo M; Schiller G; Lill M; Kunkel L; Wolin M
    Bone Marrow Transplant; 1995 Feb; 15(2):299-303. PubMed ID: 7773222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin's disease: ten years' experience of a combined lymphoma clinic. The Prince of Wales Hospital Oncology Cooperative Group (lymphoma), Sidney.
    Med J Aust; 1980 Feb; 1(3):118-21. PubMed ID: 7374519
    [No Abstract]   [Full Text] [Related]  

  • 33. Extended-field radiotherapy in the treatment of Hodgkin's disease.
    Tepmongkol P
    J Med Assoc Thai; 1982 Feb; 65(2):55-62. PubMed ID: 7077213
    [No Abstract]   [Full Text] [Related]  

  • 34. Hodgkin's disease. A pathological, clinical review of all cases treated in the Radiation Oncology Department, Saint Francis Hospital, Tulsa, Oklahoma, from September, 1968 to October, 1973.
    Brooks BC; Ellis RG; Brickner TJ; Gooden DS
    J Okla State Med Assoc; 1974 May; 67(5):196-200. PubMed ID: 4828353
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hodgkin's disease (study of 99 cases occurring during a 10-year period)].
    Delage JM; Barry A; Petitclerc C; Villeneuve B; Jobin F; Lehner-Netsch G; Lyonnais J; Leblond PF
    Union Med Can; 1978 Oct; 107(10):920-6. PubMed ID: 705954
    [No Abstract]   [Full Text] [Related]  

  • 36. Occurrence of herpes zoster varicella infections after completion of treatment for Hodgkin's disease.
    De Pauw BE; Janssen JT; Vaissier P; Haanen C
    Neth J Med; 1983; 26(10):301-3. PubMed ID: 6656975
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the curability of Hodgkin's disease].
    Glińska H
    Pol Tyg Lek; 1971 Apr; 26(16):591-5. PubMed ID: 5577333
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of therapeutic results in Hodgkin's disease].
    Hayabuchi N; Jingu K; Matsuura K; Matsui M; Niho Y; Motomura S; Ikeda M; Kikuchi M
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2008-15. PubMed ID: 7169572
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term survival of patients with Hodgkin's disease].
    Kardaszewicz S; Japa J; Luciak M; Rozek-Lesiak K; Rusinowska Z; Urgacz-Ficek J
    Pol Tyg Lek; 1979 Jan; 34(5):173-5. PubMed ID: 432131
    [No Abstract]   [Full Text] [Related]  

  • 40. [Failures in the treatment of Hodgkin's disease in children].
    Armata J; Borkowski W; Kaczor Z
    Pol Tyg Lek; 1980 Nov; 35(46):1769-71. PubMed ID: 7243639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.